UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 41 filers reported holding UROVANT SCIENCES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $50,274,000 | +127.4% | 3,116,831 | +31.7% | 0.54% | +67.2% |
Q3 2020 | $22,106,000 | -5.1% | 2,366,831 | 0.0% | 0.32% | -14.3% |
Q2 2020 | $23,289,000 | +6.7% | 2,366,831 | 0.0% | 0.38% | -33.6% |
Q1 2020 | $21,823,000 | -41.5% | 2,366,831 | -1.7% | 0.57% | -23.5% |
Q4 2019 | $37,331,000 | +75.5% | 2,406,931 | +7.1% | 0.74% | +29.5% |
Q3 2019 | $21,275,000 | +43.4% | 2,246,547 | +19.8% | 0.57% | +68.5% |
Q2 2019 | $14,835,000 | +70.6% | 1,875,426 | +116.7% | 0.34% | +38.8% |
Q1 2019 | $8,697,000 | +122.1% | 865,359 | +38.4% | 0.24% | +64.4% |
Q4 2018 | $3,915,000 | -29.5% | 625,359 | +35.2% | 0.15% | +0.7% |
Q3 2018 | $5,552,000 | – | 462,659 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|